Area of research
Epidemiology · Orthopedics and Sports Medicine
Research interest
Research interests include Neuroendocrine Tumor Research Advances, Bone health and osteoporosis research, Genetic Associations and Epidemiology, and Lung Cancer Research Studies.
Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance
Single‐cell transcriptomic analysis reveals a metastasis‐associated <scp>PCSK1</scp> <sup>+</sup> neuroendocrine subpopulation in pancreatic neuroendocrine tumors
Visualized clinical–radiomics model for predicting the efficacy of surufatinib in hepatic metastases of neuroendocrine neoplasms
A Comparative Study on the Progression of Neuroendocrine Carcinomas and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms
Development and validation of a prognostic model for overall survival in small cell carcinoma of the esophagus
TOP2A as a prognostic biomarker in small cell carcinoma of the esophagus: an integrated bioinformatics and immunohistochemical study
Single-cell transcriptomic analysis reveals epithelial and microenvironmental heterogeneity in small cell carcinoma of the esophagus
Notch1 signaling pathway contributes to sorafenib resistance in hepatocellular carcinoma by modulating the cell cycle, mitochondrial function, and epithelial–mesenchymal transition
Transarterial Chemoembolization Combined With PD-1 Inhibitors Plus Lenvatinib Showed Improved Efficacy for Treatment of Unresectable Hepatocellular Carcinoma Compared With PD-1 Inhibitors Plus Lenvatinib
Molecular typing and mutational characterization of rectal neuroendocrine neoplasms
Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells
Prognosis of hepatocellular carcinoma and its association with immune cells using systemic inflammatory response index